John Kaiser finds next CEO role at Duke spinout Evecxia; Immunocore vet Namir Hassan moves to I/O biotech Zelluna
→ Duke spinout Evecxia has recruited biopharma vet John Kaiser to steer clinical and business plans for …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
